Jose Obeso, M.D., Ph.D. - Publications

Affiliations: 
Neurociencias CIMA, Universidad de Navarra, Pamplona, Navarra, Spain 
 Neurology Universidad CEU San Pablo (Spain) 
Area:
Parkinson's Disease
Website:
http://gadeaciencia.org/teams/obeso-jose-a-2/

245 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Hernandez LF, Obeso I, Costa RM, Redgrave P, Obeso JA. Dopaminergic Vulnerability in Parkinson Disease: The Cost of Humans' Habitual Performance. Trends in Neurosciences. PMID 31053241 DOI: 10.1016/j.tins.2019.03.007  0.76
2019 Pineda-Pardo JA, Martínez-Fernández R, Rodríguez-Rojas R, Del-Alamo M, Hernández F, Foffani G, Dileone M, Máñez-Miró JU, De Luis-Pastor E, Vela L, Obeso JA. Microstructural changes of the dentato-rubro-thalamic tract after transcranial MR guided focused ultrasound ablation of the posteroventral VIM in essential tremor. Human Brain Mapping. PMID 30865338 DOI: 10.1002/hbm.24569  0.72
2019 Gasca-Salas C, Guida P, Piredda R, Obeso I, Vela Desojo L, Martínez-Fernández R, Hernández-Fernández F, Máñez-Miró J, Pineda-Pardo JA, Del Álamo M, Rodriguez-Rojas R, Mata-Marín D, Alonso-Frech F, de Luis E, Obeso JA. Cognitive safety after unilateral magnetic resonance-guided focused ultrasound thalamotomy for essential tremor. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 30850471 DOI: 10.1136/jnnp-2018-320129  0.76
2019 Bannard C, Leriche M, Bandmann O, Brown CH, Ferracane E, Sánchez-Ferro Á, Obeso J, Redgrave P, Stafford T. Reduced habit-driven errors in Parkinson's Disease. Scientific Reports. 9: 3423. PMID 30833640 DOI: 10.1038/s41598-019-39294-z  0.52
2018 Berg D, Adler CH, Bloem BR, Chan P, Gasser T, Goetz CG, Halliday G, Lang AE, Lewis S, Li Y, Liepelt-Scarfone I, Litvan I, Marek K, Maetzler C, Mi T, ... Obeso J, et al. Movement disorder society criteria for clinically established early Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 30145841 DOI: 10.1002/mds.27431  0.36
2017 Picconi B, Hernández LF, Obeso JA, Calabresi P. Motor complications in Parkinson's disease: Striatal molecular and electrophysiological mechanisms of dyskinesias. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 29219207 DOI: 10.1002/mds.27261  0.52
2017 Martínez-Fernández R, Rodríguez-Rojas R, Del Álamo M, Hernández-Fernández F, Pineda-Pardo JA, Dileone M, Alonso-Frech F, Foffani G, Obeso I, Gasca-Salas C, de Luis-Pastor E, Vela L, Obeso JA. Focused ultrasound subthalamotomy in patients with asymmetric Parkinson's disease: a pilot study. The Lancet. Neurology. PMID 29203153 DOI: 10.1016/S1474-4422(17)30403-9  0.76
2017 Blesa J, Trigo-Damas I, Dileone M, Del Rey NL, Hernandez LF, Obeso JA. Compensatory mechanisms in Parkinson's disease: Circuits adaptations and role in disease modification. Experimental Neurology. PMID 28987461 DOI: 10.1016/j.expneurol.2017.10.002  0.84
2017 Obeso JA, Stamelou M, Goetz CG, Poewe W, Lang AE, Weintraub D, Burn D, Halliday GM, Bezard E, Przedborski S, Lehericy S, Brooks DJ, Rothwell JC, Hallett M, DeLong MR, et al. Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy. Movement Disorders : Official Journal of the Movement Disorder Society. 32: 1264-1310. PMID 28887905 DOI: 10.1002/mds.27115  1
2017 Quiroga-Varela A, Aguilar E, Iglesias E, Obeso JA, Marin C. Short- and long-term effects induced by repeated 6-OHDA intraventricular administration: A new progressive and bilateral rodent model of Parkinson's disease. Neuroscience. 361: 144-156. PMID 28823819 DOI: 10.1016/j.neuroscience.2017.08.017  0.48
2017 Obeso I, Casabona E, Rodríguez-Rojas R, Bringas ML, Macías R, Pavón N, Obeso JA, Jahanshahi M. Unilateral subthalamotomy in Parkinson's disease: Cognitive, psychiatric and neuroimaging changes. Cortex; a Journal Devoted to the Study of the Nervous System and Behavior. 94: 39-48. PMID 28711816 DOI: 10.1016/j.cortex.2017.06.006  0.76
2017 Gasca-Salas C, García-Lorenzo D, Garcia-Garcia D, Clavero P, Obeso JA, Lehericy S, Rodríguez-Oroz MC. Parkinson's disease with mild cognitive impairment: severe cortical thinning antedates dementia. Brain Imaging and Behavior. PMID 28710667 DOI: 10.1007/s11682-017-9751-6  0.32
2017 Pifl C, Reither H, Del Rey NL, Cavada C, Obeso JA, Blesa J. Early Paradoxical Increase of Dopamine: A Neurochemical Study of Olfactory Bulb in Asymptomatic and Symptomatic MPTP Treated Monkeys. Frontiers in Neuroanatomy. 11: 46. PMID 28611598 DOI: 10.3389/fnana.2017.00046  0.84
2017 Blesa J, Trigo-Damas I, Del Rey NL, Obeso JA. The use of nonhuman primate models to understand processes in Parkinson's disease. Journal of Neural Transmission (Vienna, Austria : 1996). PMID 28357564 DOI: 10.1007/s00702-017-1715-x  0.84
2016 Blesa J, Trigo-Damas I, Obeso JA. Parkinson's disease and thalamus: facts and fancy. The Lancet. Neurology. 15: e2. PMID 27302241 DOI: 10.1016/S1474-4422(16)30048-5  0.84
2016 Garcia-Garcia D, Guridi J, Toledo JB, Alegre M, Obeso JA, Rodríguez-Oroz MC. Stimulation sites in the subthalamic nucleus and clinical improvement in Parkinson's disease: a new approach for active contact localization. Journal of Neurosurgery. 1-12. PMID 26848922 DOI: 10.3171/2015.9.JNS15868  0.32
2015 Gasca-Salas C, Clavero P, García-García D, Obeso JA, Rodríguez-Oroz MC. Significance of visual hallucinations and cerebral hypometabolism in the risk of dementia in Parkinson's disease patients with mild cognitive impairment. Human Brain Mapping. PMID 26663702 DOI: 10.1002/hbm.23080  0.88
2015 Hernández LF, Redgrave P, Obeso JA. Corrigendum: Habitual Behavior and Dopamine Cell Vulnerability in Parkinson Disease. Frontiers in Neuroanatomy. 9: 146. PMID 26635540 DOI: 10.3389/fnana.2015.00146  0.88
2015 Jahanshahi M, Obeso I, Rothwell JC, Obeso JA. A fronto-striato-subthalamic-pallidal network for goal-directed and habitual inhibition. Nature Reviews. Neuroscience. PMID 26530468 DOI: 10.1038/nrn4038  0.88
2015 Berg D, Postuma RB, Adler CH, Bloem BR, Chan P, Dubois B, Gasser T, Goetz CG, Halliday G, Joseph L, Lang AE, Liepelt-Scarfone I, Litvan I, Marek K, Obeso J, et al. MDS research criteria for prodromal Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 1600-11. PMID 26474317 DOI: 10.1002/mds.26431  0.88
2015 Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, et al. MDS clinical diagnostic criteria for Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 1591-601. PMID 26474316 DOI: 10.1002/mds.26424  0.88
2015 Blesa J, Lanciego JL, Obeso JA. Editorial: Parkinson's disease: cell vulnerability and disease progression. Frontiers in Neuroanatomy. 9: 125. PMID 26441555 DOI: 10.3389/fnana.2015.00125  0.88
2015 Juanes JA, Ruisoto P, Obeso JA, Prats A, San-Molina J. Computer-Based Visualization System for the Study of Deep Brain Structures Involved in Parkinson's Disease. Journal of Medical Systems. 39: 151. PMID 26370536 DOI: 10.1007/s10916-015-0348-6  0.88
2015 Hernández LF, Redgrave P, Obeso JA. Habitual behavior and dopamine cell vulnerability in Parkinson disease. Frontiers in Neuroanatomy. 9: 99. PMID 26300740 DOI: 10.3389/fnana.2015.00099  0.88
2015 Mellone M, Stanic J, Hernandez LF, Iglesias E, Zianni E, Longhi A, Prigent A, Picconi B, Calabresi P, Hirsch EC, Obeso JA, Di Luca M, Gardoni F. NMDA receptor GluN2A/GluN2B subunit ratio as synaptic trait of levodopa-induced dyskinesias: from experimental models to patients. Frontiers in Cellular Neuroscience. 9: 245. PMID 26217176 DOI: 10.3389/fncel.2015.00245  0.72
2015 Molinet-Dronda F, Gago B, Quiroga-Varela A, Juri C, Collantes M, Delgado M, Prieto E, Ecay M, Iglesias E, Marín C, Peñuelas I, Obeso JA. Monoaminergic PET imaging and histopathological correlation in unilateral and bilateral 6-hydroxydopamine lesioned rat models of Parkinson's disease: a longitudinal in-vivo study. Neurobiology of Disease. 77: 165-72. PMID 25681534 DOI: 10.1016/j.nbd.2015.01.007  0.88
2015 Guridi J, Obeso JA. Letter to the editor: Parkinson's disease and early subthalamotomy. Journal of Neurosurgery. 122: 980-1. PMID 25679280 DOI: 10.3171/2014.8.JNS141799  0.88
2015 Rothwell JC, Obeso JA. Can levodopa-induced dyskinesias go beyond the motor circuit? Brain : a Journal of Neurology. 138: 242-4. PMID 25627235 DOI: 10.1093/brain/awu365  0.88
2015 Hallett M, Obeso J. Where does chorea come from? cortical excitability findings challenge classic pathophysiological concepts. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 169-70. PMID 25546440 DOI: 10.1002/mds.26109  0.88
2015 Schneider SA, Obeso JA. Clinical and pathological features of Parkinson's disease. Current Topics in Behavioral Neurosciences. 22: 205-20. PMID 24850081 DOI: 10.1007/7854_2014_317  0.88
2015 Mellone M, Stanic J, Hernandez LF, Iglesias E, Zianni E, Longhi A, Prigent A, Picconi B, Calabresi P, Hirsch EC, Obeso JA, Luca MD, Gardoni F. NMDA receptor gluN2A/gluN2B subunit ratio as synaptic trait of levodopa-induced dyskinesias: From experimental models to patients Frontiers in Cellular Neuroscience. 9. DOI: 10.3389/fncel.2015.00245  0.88
2014 Olanow CW, Obeso J. Profile of Mahlon DeLong and Alim Benabid, 2014 Lasker-DeBakey Medical Research awardees. Proceedings of the National Academy of Sciences of the United States of America. 111: 17693-5. PMID 25489082 DOI: 10.1073/pnas.1419249111  0.36
2014 Olanow CW, Obeso JA. The end of the term. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 1703-4. PMID 25487521 DOI: 10.1002/mds.26106  0.88
2014 Standaert DG, Olanow CW, Obeso JA. Scientific perspectives. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 1230. PMID 25209257 DOI: 10.1002/mds.26015  0.88
2014 Gasca-Salas C, Estanga A, Clavero P, Aguilar-Palacio I, González-Redondo R, Obeso JA, Rodríguez-Oroz MC. Longitudinal assessment of the pattern of cognitive decline in non-demented patients with advanced Parkinson's disease. Journal of Parkinson's Disease. 4: 677-86. PMID 25208730 DOI: 10.3233/JPD-140398  0.88
2014 Olanow CW, Obeso JA. Impact factor for 2013. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 1091. PMID 25137429 DOI: 10.1002/mds.26002  0.88
2014 Obeso JA, Rodriguez-Oroz MC, Stamelou M, Bhatia KP, Burn DJ. The expanding universe of disorders of the basal ganglia. Lancet. 384: 523-31. PMID 24954674 DOI: 10.1016/S0140-6736(13)62418-6  0.88
2014 González-Redondo R, García-García D, Clavero P, Gasca-Salas C, García-Eulate R, Zubieta JL, Arbizu J, Obeso JA, Rodríguez-Oroz MC. Grey matter hypometabolism and atrophy in Parkinson's disease with cognitive impairment: a two-step process. Brain : a Journal of Neurology. 137: 2356-67. PMID 24951642 DOI: 10.1093/brain/awu159  0.88
2014 Pifl C, Rajput A, Reither H, Blesa J, Cavada C, Obeso JA, Rajput AH, Hornykiewicz O. Is Parkinson's disease a vesicular dopamine storage disorder? Evidence from a study in isolated synaptic vesicles of human and nonhuman primate striatum. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 8210-8. PMID 24920625 DOI: 10.1523/JNEUROSCI.5456-13.2014  0.88
2014 Obeso I, Wilkinson L, Casabona E, Speekenbrink M, Luisa Bringas M, Álvarez M, Álvarez L, Pavón N, Rodríguez-Oroz MC, Macías R, Obeso JA, Jahanshahi M. The subthalamic nucleus and inhibitory control: impact of subthalamotomy in Parkinson's disease. Brain : a Journal of Neurology. 137: 1470-80. PMID 24657985 DOI: 10.1093/brain/awu058  0.88
2014 Berg D, Postuma RB, Bloem B, Chan P, Dubois B, Gasser T, Goetz CG, Halliday GM, Hardy J, Lang AE, Litvan I, Marek K, Obeso J, Oertel W, Olanow CW, et al. Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 454-62. PMID 24619848 DOI: 10.1002/mds.25844  0.88
2014 Marin C, Bonastre M, Mengod G, Cortés R, Giralt A, Obeso JA, Schapira AH. Early L-dopa, but not pramipexole, restores basal ganglia activity in partially 6-OHDA-lesioned rats. Neurobiology of Disease. 64: 36-47. PMID 24370700 DOI: 10.1016/j.nbd.2013.12.009  0.88
2014 Toledo JB, López-Azcárate J, Garcia-Garcia D, Guridi J, Valencia M, Artieda J, Obeso J, Alegre M, Rodriguez-Oroz M. High beta activity in the subthalamic nucleus and freezing of gait in Parkinson's disease. Neurobiology of Disease. 64: 60-5. PMID 24361601 DOI: 10.1016/j.nbd.2013.12.005  0.88
2014 Recasens A, Dehay B, Bové J, Carballo-Carbajal I, Dovero S, Pérez-Villalba A, Fernagut PO, Blesa J, Parent A, Perier C, Fariñas I, Obeso JA, Bezard E, Vila M. Lewy body extracts from Parkinson disease brains trigger α-synuclein pathology and neurodegeneration in mice and monkeys. Annals of Neurology. 75: 351-62. PMID 24243558 DOI: 10.1002/ana.24066  0.88
2014 Merello M, Damas IT, Obeso JA. Features and mechanisms of diphasic dyskinesia in Parkinson's disease Levodopa-Induced Dyskinesia in Parkinson's Disease. 135-146. DOI: 10.1007/978-1-4471-6503-3_8  0.88
2014 Olanow CW, Obeso JA. Movement disorders-a growing journal for a growing field Movement Disorders. 29: 1-2. DOI: 10.1002/mds.25812  0.88
2013 Olanow CW, Obeso JA. The state of the journal-2013 Movement Disorders. 28: 259-260. PMID 24251888 DOI: 10.1002/mds.25423  0.88
2013 Marin C, Bonastre M, Mengod G, Cortés R, Rodríguez-Oroz MC, Obeso JA. Subthalamic 6-OHDA-induced lesion attenuates levodopa-induced dyskinesias in the rat model of Parkinson's disease. Experimental Neurology. 250: 304-12. PMID 24140562 DOI: 10.1016/j.expneurol.2013.10.006  0.88
2013 Rodriguez-Oroz MC, Obeso JA. Commentary. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 1349-50. PMID 24078331 DOI: 10.1002/mds.25681  0.88
2013 Ballaz S, Morales I, Rodríguez M, Obeso JA. Ascorbate prevents cell death from prolonged exposure to glutamate in an in vitro model of human dopaminergic neurons. Journal of Neuroscience Research. 91: 1609-17. PMID 23996657 DOI: 10.1002/jnr.23276  0.88
2013 Bézard E, Olanow CW, Obeso JA. Levodopa-induced dyskinesias in the absence of nigrostriatal degeneration. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 1023-4. PMID 23787890 DOI: 10.1002/mds.25533  0.88
2013 Quiroga-Varela A, Walters JR, Brazhnik E, Marin C, Obeso JA. What basal ganglia changes underlie the parkinsonian state? The significance of neuronal oscillatory activity. Neurobiology of Disease. 58: 242-8. PMID 23727447 DOI: 10.1016/j.nbd.2013.05.010  0.88
2013 Berg D, Lang AE, Postuma RB, Maetzler W, Deuschl G, Gasser T, Siderowf A, Schapira AH, Oertel W, Obeso JA, Olanow CW, Poewe W, Stern M. Changing the research criteria for the diagnosis of Parkinson's disease: obstacles and opportunities. The Lancet. Neurology. 12: 514-24. PMID 23582175 DOI: 10.1016/S1474-4422(13)70047-4  0.88
2013 Obeso I, Wilkinson L, Rodríguez-Oroz MC, Obeso JA, Jahanshahi M. Bilateral stimulation of the subthalamic nucleus has differential effects on reactive and proactive inhibition and conflict-induced slowing in Parkinson's disease. Experimental Brain Research. 226: 451-62. PMID 23525560 DOI: 10.1007/s00221-013-3457-9  0.88
2013 Obeso JA, Guridi J, Nambu A, Crossman AR. Motor manifestations and basal ganglia output activity: the paradox continues. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 416-8. PMID 23494928 DOI: 10.1002/mds.25358  0.88
2013 Alvarez-Erviti L, Seow Y, Schapira AH, Rodriguez-Oroz MC, Obeso JA, Cooper JM. Influence of microRNA deregulation on chaperone-mediated autophagy and α-synuclein pathology in Parkinson's disease. Cell Death & Disease. 4: e545. PMID 23492776 DOI: 10.1038/cddis.2013.73  0.88
2013 Ortega-Cubero S, Clavero P, Irurzun C, Gonzalez-Redondo R, Guridi J, Obeso JA, Rodriguez-Oroz MC. Effect of deep brain stimulation of the subthalamic nucleus on non-motor fluctuations in Parkinson's disease: two-years' follow-up. Parkinsonism & Related Disorders. 19: 543-7. PMID 23453890 DOI: 10.1016/j.parkreldis.2013.02.001  0.88
2013 Gago B, Marin C, Rodríguez-Oroz MC, Obeso JA. l-dopa-induced dyskinesias in unilateral 6-hydroxydopamine-lesioned rats are not modified by excitotoxic lesion of the entopeduncular nucleus and substantia nigra pars reticulata. Synapse (New York, N.Y.). 67: 407-14. PMID 23404474 DOI: 10.1002/syn.21652  0.88
2013 Olanow CW, Obeso JA, Stocchi F. The vatican meeting on neuroprotection for Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 1-2. PMID 23390093 DOI: 10.1002/mds.25356  0.88
2013 Pifl C, Hornykiewicz O, Blesa J, Adánez R, Cavada C, Obeso JA. Reduced noradrenaline, but not dopamine and serotonin in motor thalamus of the MPTP primate: relation to severity of parkinsonism. Journal of Neurochemistry. 125: 657-62. PMID 23331162 DOI: 10.1111/jnc.12162  0.88
2013 Schneider SA, Obeso JA. Movement disorders: improved understanding of early disease. The Lancet. Neurology. 12: 10-2. PMID 23237891 DOI: 10.1016/S1474-4422(12)70302-2  0.88
2013 Alegre M, Lopez-Azcarate J, Obeso I, Wilkinson L, Rodriguez-Oroz MC, Valencia M, Garcia-Garcia D, Guridi J, Artieda J, Jahanshahi M, Obeso JA. The subthalamic nucleus is involved in successful inhibition in the stop-signal task: a local field potential study in Parkinson's disease. Experimental Neurology. 239: 1-12. PMID 22975442 DOI: 10.1016/j.expneurol.2012.08.027  0.88
2013 Rodriguez-Rojas R, Sanabria G, Melie L, Morales JM, Carballo M, Garcia D, Obeso JA, Rodriguez-Oroz MC. Using graph theory to identify aberrant hierarchical patterns in parkinsonian brain networks Lecture Notes in Computer Science (Including Subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics). 8259: 134-141. DOI: 10.1007/978-3-642-41827-3_17  0.88
2013 Olanow CW, Obeso JA. 2012 impact factor increases to 4.558 Movement Disorders. 28: A5. DOI: 10.1002/mds.25638  0.88
2012 Guridi J, González-Redondo R, Obeso JA. Clinical features, pathophysiology, and treatment of levodopa-induced dyskinesias in Parkinson's disease. Parkinson's Disease. 2012: 943159. PMID 23125942 DOI: 10.1155/2012/943159  0.88
2012 Lanciego JL, Luquin N, Obeso JA. Functional neuroanatomy of the basal ganglia. Cold Spring Harbor Perspectives in Medicine. 2: a009621. PMID 23071379 DOI: 10.1101/cshperspect.a009621  0.88
2012 Obeso JA. Commentary for reversible pseudoathetosis induced by cervical myelopathy. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 1371. PMID 23001936 DOI: 10.1002/mds.25091  0.88
2012 Morales I, Fuentes A, Ballaz S, Obeso JA, Rodriguez M. Striatal interaction among dopamine, glutamate and ascorbate. Neuropharmacology. 63: 1308-14. PMID 22959966 DOI: 10.1016/j.neuropharm.2012.08.007  0.88
2012 Garcia-Garcia D, Clavero P, Gasca Salas C, Lamet I, Arbizu J, Gonzalez-Redondo R, Obeso JA, Rodriguez-Oroz MC. Posterior parietooccipital hypometabolism may differentiate mild cognitive impairment from dementia in Parkinson's disease. European Journal of Nuclear Medicine and Molecular Imaging. 39: 1767-77. PMID 22872307 DOI: 10.1007/s00259-012-2198-5  0.88
2012 Serrano M, Rebollo M, Depienne C, Rastetter A, Fernández-Álvarez E, Muchart J, Martorell L, Artuch R, Obeso JA, Pérez-Dueñas B. Reversible generalized dystonia and encephalopathy from thiamine transporter 2 deficiency. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 1295-8. PMID 22777947 DOI: 10.1002/mds.25008  0.88
2012 Alegre M, López-Azcárate J, Alonso-Frech F, Rodríguez-Oroz MC, Valencia M, Guridi J, Artieda J, Obeso JA. Subthalamic activity during diphasic dyskinesias in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 1178-81. PMID 22744752 DOI: 10.1002/mds.25090  0.88
2012 Blesa J, Pifl C, Sánchez-González MA, Juri C, García-Cabezas MA, Adánez R, Iglesias E, Collantes M, Peñuelas I, Sánchez-Hernández JJ, Rodríguez-Oroz MC, Avendaño C, Hornykiewicz O, Cavada C, Obeso JA. The nigrostriatal system in the presymptomatic and symptomatic stages in the MPTP monkey model: a PET, histological and biochemical study. Neurobiology of Disease. 48: 79-91. PMID 22677034 DOI: 10.1016/j.nbd.2012.05.018  0.88
2012 Guridi J, Rodriguez-Oroz MC, Alegre M, Obeso JA. Hardware complications in deep brain stimulation: electrode impedance and loss of clinical benefit. Parkinsonism & Related Disorders. 18: 765-9. PMID 22522071 DOI: 10.1016/j.parkreldis.2012.03.014  0.88
2012 Olanow CW, Obeso JA. The significance of defining preclinical or prodromal Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 666-9. PMID 22508285 DOI: 10.1002/mds.25019  0.88
2012 Alegre M, Hallett M, Olanow CW, Obeso JA. Technical advances in deep brain stimulation: how far is enough? Movement Disorders : Official Journal of the Movement Disorder Society. 27: 341-2. PMID 22411845 DOI: 10.1002/mds.24965  0.88
2012 Aron AR, Obeso J. Is executive control used to compensate for involuntary movements in levodopa-induced dyskinesia? Movement Disorders : Official Journal of the Movement Disorder Society. 27: 339-40. PMID 22411844 DOI: 10.1002/mds.24936  0.88
2012 Lang AE, Obeso JA. Stem cell therapy for Parkinson's disease. Annals of Neurology. 71: 283; author reply 28. PMID 22368000 DOI: 10.1002/ana.22676  0.88
2012 Lorenzo-Betancor O, Samaranch L, Ezquerra M, Tolosa E, Lorenzo E, Irigoyen J, Gaig C, Pastor MA, Soto-Ortolaza AI, Ross OA, Rodríguez-Oroz MC, Valldeoriola F, Martí MJ, Luquin MR, Perez-Tur J, ... ... Obeso JA, et al. LRRK2 haplotype-sharing analysis in Parkinson's disease reveals a novel p.S1761R mutation. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 146-51. PMID 22038903 DOI: 10.1002/mds.23968  0.88
2011 Blesa J, Juri C, García-Cabezas MÁ, Adánez R, Sánchez-González MÁ, Cavada C, Obeso JA. Inter-hemispheric asymmetry of nigrostriatal dopaminergic lesion: a possible compensatory mechanism in Parkinson's disease. Frontiers in Systems Neuroscience. 5: 92. PMID 22287944 DOI: 10.3389/fnsys.2011.00092  0.88
2011 Obeso JA, Olanow W. Deep brain stimulation for Parkinson's disease: thinking about the long-term in the short-term. Movement Disorders : Official Journal of the Movement Disorder Society. 26: 2303-4. PMID 22109849 DOI: 10.1002/mds.24036  0.88
2011 Obeso JA, Olanow W. Continuing efforts to obtain continuous delivery of levodopa. Movement Disorders : Official Journal of the Movement Disorder Society. 26: 2149-50. PMID 22021155 DOI: 10.1002/mds.23996  0.88
2011 Olanow CW, Obeso JA. Levodopa toxicity and Parkinson disease: still a need for equipoise. Neurology. 77: 1416-7. PMID 21917774 DOI: 10.1212/WNL.0b013e318232ac0a  0.88
2011 Prieto E, Collantes M, Delgado M, Juri C, García-García L, Molinet F, Fernández-Valle ME, Pozo MA, Gago B, Martí-Climent JM, Obeso JA, Peñuelas I. Statistical parametric maps of ¹⁸F-FDG PET and 3-D autoradiography in the rat brain: a cross-validation study. European Journal of Nuclear Medicine and Molecular Imaging. 38: 2228-37. PMID 21874322 DOI: 10.1007/s00259-011-1905-y  0.88
2011 Obeso JA, Lanciego JL. Past, present, and future of the pathophysiological model of the Basal Ganglia. Frontiers in Neuroanatomy. 5: 39. PMID 21808607 DOI: 10.3389/fnana.2011.00039  0.88
2011 Cerquetti D, Obeso JA, Merello M. Neuronal discharge patterns in the globus pallidus pars interna in a patient with Parkinson's disease and hemiballismus secondary to subthalamotomy. Experimental Brain Research. 213: 447-55. PMID 21786135 DOI: 10.1007/s00221-011-2794-9  0.88
2011 Olanow CW, Obeso JA. Movement disorders 2011--the state of the journal. Movement Disorders : Official Journal of the Movement Disorder Society. 26: 1183-4. PMID 21692104 DOI: 10.1002/mds.23840  0.88
2011 Obeso I, Wilkinson L, Casabona E, Bringas ML, Álvarez M, Álvarez L, Pavón N, Rodríguez-Oroz MC, Macías R, Obeso JA, Jahanshahi M. Deficits in inhibitory control and conflict resolution on cognitive and motor tasks in Parkinson's disease. Experimental Brain Research. 212: 371-84. PMID 21643718 DOI: 10.1007/s00221-011-2736-6  0.88
2011 Wichmann T, DeLong MR, Guridi J, Obeso JA. Milestones in research on the pathophysiology of Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 26: 1032-41. PMID 21626548 DOI: 10.1002/mds.23695  0.88
2011 Meissner WG, Frasier M, Gasser T, Goetz CG, Lozano A, Piccini P, Obeso JA, Rascol O, Schapira A, Voon V, Weiner DM, Tison F, Bezard E. Priorities in Parkinson's disease research. Nature Reviews. Drug Discovery. 10: 377-93. PMID 21532567 DOI: 10.1038/nrd3430  0.88
2011 Rodriguez-Oroz MC, López-Azcárate J, Garcia-Garcia D, Alegre M, Toledo J, Valencia M, Guridi J, Artieda J, Obeso JA. Involvement of the subthalamic nucleus in impulse control disorders associated with Parkinson's disease. Brain : a Journal of Neurology. 134: 36-49. PMID 21059746 DOI: 10.1093/brain/awq301  0.88
2011 Cubo E, López MD, Ceberio JI, Alfonso IL, Martinez BM, Berciano J, Iglesias F, Obeso JA. Striatal dopamine function in a family with multiple SCA-3 phenotypes. Journal of Neurology. 258: 308-10. PMID 20809346 DOI: 10.1007/s00415-010-5724-z  0.88
2011 Olanow CW, Obeso J. The Movement Disorders journal-Then and now Movement Disorders. 26: 935-936. DOI: 10.1002/mds.23758  0.88
2011 Olanow CW, Obeso JA. Movement Disorders - Twenty-Five years ... and Still Growing Movement Disorders. 26: 1. DOI: 10.1002/mds.23625  0.88
2011 Juri C, Rodriguez-Oroz MC, Obeso JA. Functional Organization of the Basal Ganglia: Dopaminergic and Non-Dopaminergic Features Parkinson's Disease: Non-Motor and Non-Dopaminergic Features. 56-69. DOI: 10.1002/9781444397970.ch5  0.88
2010 Obeso JA. Modeling clinical features of neurodegeneration. Nature Medicine. 16: 1372. PMID 21135843 DOI: 10.1038/nm1210-1372b  0.88
2010 Marin C, Obeso JA. Catechol-O-methyltransferase inhibitors in preclinical models as adjuncts of L-dopa treatment. International Review of Neurobiology. 95: 191-205. PMID 21095463 DOI: 10.1016/B978-0-12-381326-8.00008-9  0.88
2010 Redgrave P, Rodriguez M, Smith Y, Rodriguez-Oroz MC, Lehericy S, Bergman H, Agid Y, DeLong MR, Obeso JA. Goal-directed and habitual control in the basal ganglia: implications for Parkinson's disease. Nature Reviews. Neuroscience. 11: 760-72. PMID 20944662 DOI: 10.1038/nrn2915  0.88
2010 Krack P, Hariz MI, Baunez C, Guridi J, Obeso JA. Deep brain stimulation: from neurology to psychiatry? Trends in Neurosciences. 33: 474-84. PMID 20832128 DOI: 10.1016/j.tins.2010.07.002  0.88
2010 Alvarez-Erviti L, Rodriguez-Oroz MC, Cooper JM, Caballero C, Ferrer I, Obeso JA, Schapira AH. Chaperone-mediated autophagy markers in Parkinson disease brains. Archives of Neurology. 67: 1464-72. PMID 20697033 DOI: 10.1001/archneurol.2010.198  0.88
2010 Stocchi F, Zappia M, Dall'Armi V, Kulisevsky J, Lamberti P, Obeso JA. Melevodopa/carbidopa effervescent formulation in the treatment of motor fluctuations in advanced Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 1881-7. PMID 20669296 DOI: 10.1002/mds.23206  0.88
2010 Bickel S, Alvarez L, Macias R, Pavon N, Leon M, Fernandez C, Houghton DJ, Salazar S, Rodríguez-Oroz MC, Juncos J, Guridi J, Delong M, Obeso JA, Litvan I. Cognitive and neuropsychiatric effects of subthalamotomy for Parkinson's disease. Parkinsonism & Related Disorders. 16: 535-9. PMID 20650671 DOI: 10.1016/j.parkreldis.2010.06.008  0.88
2010 Obeso JA, Rodriguez-Oroz MC, Goetz CG, Marin C, Kordower JH, Rodriguez M, Hirsch EC, Farrer M, Schapira AH, Halliday G. Missing pieces in the Parkinson's disease puzzle. Nature Medicine. 16: 653-61. PMID 20495568 DOI: 10.1038/nm.2165  0.88
2010 López-Azcárate J, Tainta M, Rodríguez-Oroz MC, Valencia M, González R, Guridi J, Iriarte J, Obeso JA, Artieda J, Alegre M. Coupling between beta and high-frequency activity in the human subthalamic nucleus may be a pathophysiological mechanism in Parkinson's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 6667-77. PMID 20463229 DOI: 10.1523/JNEUROSCI.5459-09.2010  0.88
2010 Rico AJ, Barroso-Chinea P, Conte-Perales L, Roda E, Gómez-Bautista V, Gendive M, Obeso JA, Lanciego JL. A direct projection from the subthalamic nucleus to the ventral thalamus in monkeys. Neurobiology of Disease. 39: 381-92. PMID 20452426 DOI: 10.1016/j.nbd.2010.05.004  0.88
2010 Stocchi F, Jenner P, Obeso JA. When do levodopa motor fluctuations first appear in Parkinson's disease? European Neurology. 63: 257-66. PMID 20332641 DOI: 10.1159/000300647  0.88
2010 Blesa J, Juri C, Collantes M, Peñuelas I, Prieto E, Iglesias E, Martí-Climent J, Arbizu J, Zubieta JL, Rodríguez-Oroz MC, García-García D, Richter JA, Cavada C, Obeso JA. Progression of dopaminergic depletion in a model of MPTP-induced Parkinsonism in non-human primates. An (18)F-DOPA and (11)C-DTBZ PET study. Neurobiology of Disease. 38: 456-63. PMID 20304066 DOI: 10.1016/j.nbd.2010.03.006  0.88
2010 Moro E, Lozano AM, Pollak P, Agid Y, Rehncrona S, Volkmann J, Kulisevsky J, Obeso JA, Albanese A, Hariz MI, Quinn NP, Speelman JD, Benabid AL, Fraix V, Mendes A, et al. Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 578-86. PMID 20213817 DOI: 10.1002/mds.22735  0.88
2010 Obeso JA, Olanow CW. A changing journal for a changing field. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 255-6. PMID 20187103 DOI: 10.1002/mds.23051  0.88
2010 Alegre M, Rodríguez-Oroz MC, Valencia M, Pérez-Alcázar M, Guridi J, Iriarte J, Obeso JA, Artieda J. Changes in subthalamic activity during movement observation in Parkinson's disease: is the mirror system mirrored in the basal ganglia? Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 121: 414-25. PMID 20006544 DOI: 10.1016/j.clinph.2009.11.013  0.88
2010 Juri C, Rodríguez-Oroz MC, Burguera JA, Guridi J, Obeso JA. Pain and dyskinesia in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 130-2. PMID 19938158 DOI: 10.1002/mds.22874  0.88
2010 Samaranch L, Lorenzo E, Pastor MA, Riverol M, Luquin MR, Rodríguez-Oroz MC, Obeso JA, Pastor P. Analysis of the GIGYF2 gene in familial and sporadic Parkinson disease in the Spanish population. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 17: 321-5. PMID 19845746 DOI: 10.1111/j.1468-1331.2009.02812.x  0.88
2010 Juri C, Rodriguez-Oroz M, Obeso JA. The pathophysiological basis of sensory disturbances in Parkinson's disease. Journal of the Neurological Sciences. 289: 60-5. PMID 19758602 DOI: 10.1016/j.jns.2009.08.018  0.88
2010 Valldeoriola F, Regidor I, Mínguez-Castellanos A, Lezcano E, García-Ruiz P, Rojo A, Salvador A, Castro A, Grandas F, Kulisevsky J, Martí MJ, Martínez-Martín P, Relova L, Rumià J, Cámara A, ... ... Obeso J, et al. Efficacy and safety of pallidal stimulation in primary dystonia: results of the Spanish multicentric study. Journal of Neurology, Neurosurgery, and Psychiatry. 81: 65-9. PMID 19744963 DOI: 10.1136/jnnp.2009.174342  0.88
2010 Kordower JH, Halliday G, Obeso JA. Kordower, Halliday and Obeso reply Nature Medicine. 16: 961. DOI: 10.1038/nm0910-961a  0.88
2010 Rodriguez-Oroz MC, Matsubara JM, Clavero P, Guridi J, Obeso JA. Deep Brain Stimulation and Parkinson's Disease Encyclopedia of Neuroscience. 375-384. DOI: 10.1016/B978-008045046-9.01135-9  0.88
2010 Olanow CW, Obeso JA. The baton is passed Movement Disorders. 25: 1. DOI: 10.1002/mds.23020  0.88
2009 Olanow CW, Kordower JH, Lang AE, Obeso JA. Dopaminergic transplantation for Parkinson's disease: current status and future prospects. Annals of Neurology. 66: 591-6. PMID 19938101 DOI: 10.1002/ana.21778  0.88
2009 Voon V, Fernagut PO, Wickens J, Baunez C, Rodriguez M, Pavon N, Juncos JL, Obeso JA, Bezard E. Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders. The Lancet. Neurology. 8: 1140-9. PMID 19909912 DOI: 10.1016/S1474-4422(09)70287-X  0.88
2009 Rodriguez-Oroz MC, Jahanshahi M, Krack P, Litvan I, Macias R, Bezard E, Obeso JA. Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms. The Lancet. Neurology. 8: 1128-39. PMID 19909911 DOI: 10.1016/S1474-4422(09)70293-5  0.88
2009 Obeso JA, Jahanshahi M, Alvarez L, Macias R, Pedroso I, Wilkinson L, Pavon N, Day B, Pinto S, Rodríguez-Oroz MC, Tejeiro J, Artieda J, Talelli P, Swayne O, Rodríguez R, et al. What can man do without basal ganglia motor output? The effect of combined unilateral subthalamotomy and pallidotomy in a patient with Parkinson's disease. Experimental Neurology. 220: 283-92. PMID 19744484 DOI: 10.1016/j.expneurol.2009.08.030  0.88
2009 Guridi J, García-Ruiz PJ, Rodríguez-Oroz MC, Valldeoriola F, Del Álamo M, Alberdi JA, Albisua J, Aparicio MA, Ayerbe J, Barcia JA, Bilbao G, Botella C, Catalán MJ, Castro A, De Fàbregues O, ... ... Obeso J, et al. Consensus statement on deep brain stimulation in Parkinson's disease | Documento de consenso sobre estimulación cerebral profunda en la enfermedad de Parkinson Revista De Neurologia. 49: 327-331. PMID 19728280  0.88
2009 Marin C, Aguilar E, Mengod G, Cortés R, Obeso JA. Effects of early vs. late initiation of levodopa treatment in hemiparkinsonian rats. The European Journal of Neuroscience. 30: 823-32. PMID 19712101 DOI: 10.1111/j.1460-9568.2009.06877.x  0.88
2009 Halliday G, Herrero MT, Murphy K, McCann H, Ros-Bernal F, Barcia C, Mori H, Blesa FJ, Obeso JA. No Lewy pathology in monkeys with over 10 years of severe MPTP Parkinsonism. Movement Disorders : Official Journal of the Movement Disorder Society. 24: 1519-23. PMID 19526568 DOI: 10.1002/mds.22481  0.88
2009 Rodriguez-Oroz MC, Lage PM, Sanchez-Mut J, Lamet I, Pagonabarraga J, Toledo JB, García-Garcia D, Clavero P, Samaranch L, Irurzun C, Matsubara JM, Irigoien J, Bescos E, Kulisevsky J, Pérez-Tur J, ... Obeso JA, et al. Homocysteine and cognitive impairment in Parkinson's disease: a biochemical, neuroimaging, and genetic study. Movement Disorders : Official Journal of the Movement Disorder Society. 24: 1437-44. PMID 19452554 DOI: 10.1002/mds.22522  0.88
2009 Collantes M, Prieto E, Peñuelas I, Blesa J, Juri C, Martí-Climent JM, Quincoces G, Arbizu J, Riverol M, Zubieta JL, Rodriguez-Oroz MC, Luquin MR, Richter JA, Obeso JA. New MRI, 18F-DOPA and 11C-(+)-alpha-dihydrotetrabenazine templates for Macaca fascicularis neuroimaging: advantages to improve PET quantification. Neuroimage. 47: 533-9. PMID 19422919 DOI: 10.1016/j.neuroimage.2009.04.078  0.88
2009 Volkmann J, Albanese A, Kulisevsky J, Tornqvist AL, Houeto JL, Pidoux B, Bonnet AM, Mendes A, Benabid AL, Fraix V, Van Blercom N, Xie J, Obeso J, Rodriguez-Oroz MC, Guridi J, et al. Long-term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 24: 1154-61. PMID 19412954 DOI: 10.1002/mds.22496  0.88
2009 Vaamonde J, Flores JM, Weisser R, Ibañez R, Obeso JA. The duration of the motor response to apomorphine boluses is conditioned by the length of a prior infusion in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 24: 762-5. PMID 19224589 DOI: 10.1002/mds.22234  0.88
2009 Alvarez L, Macias R, Pavón N, López G, Rodríguez-Oroz MC, Rodríguez R, Alvarez M, Pedroso I, Teijeiro J, Fernández R, Casabona E, Salazar S, Maragoto C, Carballo M, García I, ... ... Obeso JA, et al. Therapeutic efficacy of unilateral subthalamotomy in Parkinson's disease: results in 89 patients followed for up to 36 months. Journal of Neurology, Neurosurgery, and Psychiatry. 80: 979-85. PMID 19204026 DOI: 10.1136/jnnp.2008.154948  0.88
2009 Marin C, Aguilar E, Rodríguez-Oroz MC, Bartoszyk GD, Obeso JA. Local administration of sarizotan into the subthalamic nucleus attenuates levodopa-induced dyskinesias in 6-OHDA-lesioned rats. Psychopharmacology. 204: 241-50. PMID 19159919 DOI: 10.1007/s00213-008-1452-9  0.88
2009 Urrestarazu E, Iriarte J, Alegre M, Guridi J, Rodríguez-Oroz MC, Obeso J, Viteri C, Artieda J. Subthalamic role on the generation of spikes in temporal epilepsy. Epilepsy Research. 83: 257-60. PMID 19056246 DOI: 10.1016/j.eplepsyres.2008.10.003  0.88
2009 Olanow CW, Gracies JM, Goetz CG, Stoessl AJ, Freeman T, Kordower JH, Godbold J, Obeso JA. Clinical pattern and risk factors for dyskinesias following fetal nigral transplantation in Parkinson's disease: a double blind video-based analysis. Movement Disorders : Official Journal of the Movement Disorder Society. 24: 336-43. PMID 19006186 DOI: 10.1002/mds.22208  0.88
2009 Urrestarazu E, Iriarte J, Alegre M, Clavero P, Rodríguez-Oroz MC, Guridi J, Obeso JA, Artieda J. Beta activity in the subthalamic nucleus during sleep in patients with Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 24: 254-60. PMID 18951542 DOI: 10.1002/mds.22351  0.88
2009 Obeso JA, Schapira AH. Compensatory mechanisms in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 24: 153-4. PMID 18649387 DOI: 10.1002/mds.22177  0.88
2009 Obeso JA, Olanow CW. Reply to Montgomery Annals of Neurology. 65: 618-619. DOI: 10.1002/ana.21727  0.88
2008 Obeso JA, Marin C, Rodriguez-Oroz C, Blesa J, Benitez-Temiño B, Mena-Segovia J, Rodríguez M, Olanow CW. The basal ganglia in Parkinson's disease: current concepts and unexplained observations. Annals of Neurology. 64: S30-46. PMID 19127584 DOI: 10.1002/ana.21481  0.88
2008 Obeso JA, Rodríguez-Oroz MC, Benitez-Temino B, Blesa FJ, Guridi J, Marin C, Rodriguez M. Functional organization of the basal ganglia: therapeutic implications for Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 23: S548-59. PMID 18781672 DOI: 10.1002/mds.22062  0.88
2008 Olanow CW, Lees A, Obeso J. Levodopa therapy for Parkinson's disease: challenges and future prospects. Movement Disorders : Official Journal of the Movement Disorder Society. 23: S495-6. PMID 18781670 DOI: 10.1002/mds.22048  0.88
2008 Marin C, Aguilar E, Mengod G, Cortés R, Rodríguez-Oroz MC, Obeso JA. Entacapone potentiates the long-duration response but does not normalize levodopa-induced molecular changes. Neurobiology of Disease. 32: 340-8. PMID 18722529 DOI: 10.1016/j.nbd.2008.07.019  0.88
2008 Guridi J, Rodriguez-Oroz MC, Arbizu J, Alegre M, Prieto E, Landecho I, Manrique M, Artieda J, Obeso JA. Successful thalamic deep brain stimulation for orthostatic tremor. Movement Disorders : Official Journal of the Movement Disorder Society. 23: 1808-11. PMID 18671286 DOI: 10.1002/mds.22001  0.88
2008 Villoslada P, Moreno B, Melero I, Pablos JL, Martino G, Uccelli A, Montalban X, Avila J, Rivest S, Acarin L, Appel S, Khoury SJ, McGeer P, Ferrer I, Delgado M, ... Obeso J, et al. Immunotherapy for neurological diseases. Clinical Immunology (Orlando, Fla.). 128: 294-305. PMID 18534912 DOI: 10.1016/j.clim.2008.04.003  0.88
2008 Muñoz J, Fernández-Irigoyen J, Santamaría E, Parbel A, Obeso J, Corrales FJ. Mass spectrometric characterization of mitochondrial complex I NDUFA10 variants. Proteomics. 8: 1898-908. PMID 18442173 DOI: 10.1002/pmic.200701085  0.88
2008 Rodriguez-Oroz MC, Rodriguez M, Leiva C, Rodriguez-Palmero M, Nieto J, Garcia-Garcia D, Luis Zubieta J, Cardiel C, Obeso JA. Neuronal activity of the red nucleus in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 23: 908-11. PMID 18383534 DOI: 10.1002/mds.22000  0.88
2008 Guridi J, Obeso JA, Rodriguez-Oroz MC, Lozano AA, Manrique M. L-dopa-induced dyskinesia and stereotactic surgery for Parkinson's disease. Neurosurgery. 62: 311-23; discussion 3. PMID 18382309 DOI: 10.1227/01.neu.0000315998.58022.55  0.88
2008 Collantes M, Peñuelas I, Alvarez-Erviti L, Blesa J, Martí-Climent JM, Quincoces G, Delgado M, Ecay M, Martínez A, Arbizu J, Rodríguez-Oroz MC, Obeso J, Richter JA. [Use of 11C-(+)-alpha -dihydrotetrabenazine for the assessment of dopaminergic innervation in animal models of Parkinson's disease]. Revista EspañOla De Medicina Nuclear. 27: 103-11. PMID 18367048 DOI: 10.1157/13117191  0.88
2008 Quincoces G, Collantes M, Catalán R, Ecay M, Prieto E, Martino E, Blesa FJ, Alvarez-Erviti L, Areses P, Arbizu J, Obeso JA, Martí-Climent JM, Richter JA, Peñuelas I. [Quick and simple synthesis of (11)C-(+)-alpha-dihydrotetrabenazine to be used as a PET radioligand of vesicular monoamine transporters]. Revista EspañOla De Medicina Nuclear. 27: 13-21. PMID 18208777 DOI: 10.1157/13114365  0.88
2008 Lanciego JL, Rodríguez-Oroz MC, Blesa FJ, Alvarez-Erviti L, Guridi J, Barroso-Chinea P, Smith Y, Obeso JA. Lesion of the centromedian thalamic nucleus in MPTP-treated monkeys. Movement Disorders : Official Journal of the Movement Disorder Society. 23: 708-15. PMID 18175345 DOI: 10.1002/mds.21906  0.88
2007 Obeso JA, Merello M, Rodríguez-Oroz MC, Marin C, Guridi J, Alvarez L. Levodopa-induced dyskinesias in Parkinson's disease. Handbook of Clinical Neurology. 84: 185-218. PMID 18808949 DOI: 10.1016/S0072-9752(07)84040-1  0.88
2007 Rodriguez M, Alvarez-Erviti L, Blesa FJ, Rodríguez-Oroz MC, Arina A, Melero I, Ramos LI, Obeso JA. Bone-marrow-derived cell differentiation into microglia: a study in a progressive mouse model of Parkinson's disease. Neurobiology of Disease. 28: 316-25. PMID 17897835 DOI: 10.1016/j.nbd.2007.07.024  0.88
2007 Marin C, Aguilar E, Mengod G, Cortés R, Obeso JA. Concomitant short- and long-duration response to levodopa in the 6-OHDA-lesioned rat: a behavioural and molecular study. The European Journal of Neuroscience. 25: 259-69. PMID 17241287 DOI: 10.1111/j.1460-9568.2006.05265.x  0.88
2007 Rodríguez M, Morales I, González-Mora JL, Gómez I, Sabaté M, Dopico JG, Rodríguez-Oroz MC, Obeso JA. Different levodopa actions on the extracellular dopamine pools in the rat striatum. Synapse (New York, N.Y.). 61: 61-71. PMID 17117421 DOI: 10.1002/syn.20342  0.88
2006 Schapira AH, Bezard E, Brotchie J, Calon F, Collingridge GL, Ferger B, Hengerer B, Hirsch E, Jenner P, Le Novère N, Obeso JA, Schwarzschild MA, Spampinato U, Davidai G. Novel pharmacological targets for the treatment of Parkinson's disease. Nature Reviews. Drug Discovery. 5: 845-54. PMID 17016425 DOI: 10.1038/nrd2087  0.88
2006 Olanow CW, Obeso JA, Stocchi F. Drug insight: Continuous dopaminergic stimulation in the treatment of Parkinson's disease. Nature Clinical Practice. Neurology. 2: 382-92. PMID 16932589 DOI: 10.1038/ncpneuro0222  0.88
2006 Obeso JA, Rodriguez-Oroz MC, Javier Blesa F, Guridi J. The globus pallidus pars externa and Parkinson's disease. Ready for prime time? Experimental Neurology. 202: 1-7. PMID 16920102 DOI: 10.1016/j.expneurol.2006.07.004  0.88
2006 Olanow CW, Obeso JA, Stocchi F. Continuous dopamine-receptor treatment of Parkinson's disease: scientific rationale and clinical implications. The Lancet. Neurology. 5: 677-87. PMID 16857573 DOI: 10.1016/S1474-4422(06)70521-X  0.88
2006 Alonso-Frech F, Zamarbide I, Alegre M, Rodríguez-Oroz MC, Guridi J, Manrique M, Valencia M, Artieda J, Obeso JA. Slow oscillatory activity and levodopa-induced dyskinesias in Parkinson's disease. Brain : a Journal of Neurology. 129: 1748-57. PMID 16684788 DOI: 10.1093/brain/awl103  0.88
2006 Marin C, Aguilar E, Obeso JA. Coadministration of entacapone with levodopa attenuates the severity of dyskinesias in hemiparkinsonian rats. Movement Disorders : Official Journal of the Movement Disorder Society. 21: 646-53. PMID 16437585 DOI: 10.1002/mds.20780  0.88
2006 Marin C, Rodriguez-Oroz MC, Obeso JA. Motor complications in Parkinson's disease and the clinical significance of rotational behavior in the rat: have we wasted our time? Experimental Neurology. 197: 269-74. PMID 16375892 DOI: 10.1016/j.expneurol.2005.11.002  0.48
2006 Obeso JA, Lang AE. Evolution of Parkinson's disease and treatment requirements: What new treatments are needed and the role of striatal grafting Restorative Therapies in Parkinson's Disease. 50-64. DOI: 10.1007/0-387-32823-2_3  0.88
2005 Alegre M, Alonso-Frech F, Rodríguez-Oroz MC, Guridi J, Zamarbide I, Valencia M, Manrique M, Obeso JA, Artieda J. Movement-related changes in oscillatory activity in the human subthalamic nucleus: ipsilateral vs. contralateral movements. The European Journal of Neuroscience. 22: 2315-24. PMID 16262669 DOI: 10.1111/j.1460-9568.2005.04409.x  1
2005 Iravani MM, Costa S, Al-Bargouthy G, Jackson MJ, Zeng BY, Kuoppamäki M, Obeso JA, Jenner P. Unilateral pallidotomy in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated common marmosets exhibiting levodopa-induced dyskinesia. The European Journal of Neuroscience. 22: 1305-18. PMID 16190886 DOI: 10.1111/j.1460-9568.2005.04308.x  0.88
2005 Rodriguez-Oroz MC, Obeso JA, Lang AE, Houeto JL, Pollak P, Rehncrona S, Kulisevsky J, Albanese A, Volkmann J, Hariz MI, Quinn NP, Speelman JD, Guridi J, Zamarbide I, Gironell A, et al. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up. Brain : a Journal of Neurology. 128: 2240-9. PMID 15975946 DOI: 10.1093/brain/awh571  0.88
2005 Castro A, Valldeoriola F, Linazasoro G, Rodriguez-Oroz MC, Stochi F, Marin C, Rodriguez M, Vaamonde J, Jenner P, Alvarez L, Pavon N, Macias R, Luquin MR, Hernandez B, Grandas F, ... ... Obeso JA, et al. [Optimization of use of levodopa in Parkinson's disease: role of levodopa-carbidopa-entacapone combination]. Neurología (Barcelona, Spain). 20: 180-8. PMID 15891947  0.88
2005 Marin C, Aguilar E, Bonastre M, Tolosa E, Obeso JA. Early administration of entacapone prevents levodopa-induced motor fluctuations in hemiparkinsonian rats. Experimental Neurology. 192: 184-93. PMID 15698633 DOI: 10.1016/j.expneurol.2004.10.008  0.48
2005 Alvarez L, Macias R, Lopez G, Alvarez E, Pavon N, Rodriguez-Oroz MC, Juncos JL, Maragoto C, Guridi J, Litvan I, Tolosa ES, Koller W, Vitek J, DeLong MR, Obeso JA. Bilateral subthalamotomy in Parkinson's disease: initial and long-term response. Brain : a Journal of Neurology. 128: 570-83. PMID 15689366 DOI: 10.1093/brain/awh397  0.88
2005 Castle M, Aymerich MS, Sanchez-Escobar C, Gonzalo N, Obeso JA, Lanciego JL. Thalamic innervation of the direct and indirect basal ganglia pathways in the rat: Ipsi- and contralateral projections. The Journal of Comparative Neurology. 483: 143-53. PMID 15678473 DOI: 10.1002/cne.20421  0.88
2004 Lanciego JL, Gonzalo N, Rodríguez-Oroz MC, Rodríguez M, Obeso JA. ["Neurorestorative" cell therapy in Parkinson's disease: an unresolved debate]. Anales Del Sistema Sanitario De Navarra. 27: 299-304. PMID 15644883  0.36
2004 Rodriguez-Oroz MC, Zamarbide I, Guridi J, Palmero MR, Obeso JA. Efficacy of deep brain stimulation of the subthalamic nucleus in Parkinson's disease 4 years after surgery: double blind and open label evaluation. Journal of Neurology, Neurosurgery, and Psychiatry. 75: 1382-5. PMID 15377681 DOI: 10.1136/jnnp.2003.031294  0.88
2004 Olanow CW, Agid Y, Mizuno Y, Albanese A, Bonuccelli U, Bonucelli U, Damier P, De Yebenes J, Gershanik O, Guttman M, Grandas F, Hallett M, Hornykiewicz O, Jenner P, Katzenschlager R, ... ... Obeso JA, et al. Levodopa in the treatment of Parkinson's disease: current controversies. Movement Disorders : Official Journal of the Movement Disorder Society. 19: 997-1005. PMID 15372588 DOI: 10.1002/mds.20243  0.88
2004 Obeso JA, Rodriguez-Oroz MC, Lanciego JL, Rodriguez Diaz M. How does Parkinson's disease begin? The role of compensatory mechanisms. Trends in Neurosciences. 27: 125-7; author reply . PMID 15036875 DOI: 10.1016/j.tins.2003.12.006  0.88
2004 Lanciego JL, Gonzalo N, Castle M, Sanchez-Escobar C, Aymerich MS, Obeso JA. Thalamic innervation of striatal and subthalamic neurons projecting to the rat entopeduncular nucleus. The European Journal of Neuroscience. 19: 1267-77. PMID 15016084 DOI: 10.1111/j.1460-9568.2004.03244.x  0.88
2004 Obeso JA, Rodriguez-Oroz M, Marin C, Alonso F, Zamarbide I, Lanciego JL, Rodriguez-Diaz M. The origin of motor fluctuations in Parkinson's disease: importance of dopaminergic innervation and basal ganglia circuits. Neurology. 62: S17-30. PMID 14718677  0.48
2003 López-Flores G, Miguel-Morales J, Teijeiro-Amador J, Vitek J, Perez-Parra S, Fernández-Melo R, Maragoto C, Alvarez E, Alvarez L, Macías R, Obeso JA. Anatomic and neurophysiological methods for the targeting and lesioning of the subthalamic nucleus: Cuban experience and review. Neurosurgery. 52: 817-30; discussion 8. PMID 12657177  0.88
2002 Obeso JA, Bhatia K, Rothwell JC. The contribution of C. David Marsden to the study and treatment of myoclonus. Advances in Neurology. 89: 1-12. PMID 11968434  1
2002 Guridi J, Rodríguez-Oroz MC, Ramos E, Linazasoro G, Obeso JA. [Discrepancy between imaging and neurophysiology in deep brain stimulation of medial pallidum and subthalamic nucleus in Parkinson's disease]. Neurología (Barcelona, Spain). 17: 183-92. PMID 11940406  1
2001 Rodriguez-Oroz MC, Rodriguez M, Guridi J, Mewes K, Chockkman V, Vitek J, DeLong MR, Obeso JA. The subthalamic nucleus in Parkinson's disease: somatotopic organization and physiological characteristics. Brain : a Journal of Neurology. 124: 1777-90. PMID 11522580  0.88
2001 Obeso JA, Rodriguez MC, Guridi J, Alvarez L, Alvarez E, Macias R, Juncos JL, DeLong M. Lesion of the basal ganglia and surgery for Parkinson disease. Archives of Neurology. 58: 1165-6. PMID 11448310  0.88
2001 Alvarez L, Macias R, Guridi J, Lopez G, Alvarez E, Maragoto C, Teijeiro J, Torres A, Pavon N, Rodriguez-Oroz MC, Ochoa L, Hetherington H, Juncos J, DeLong MR, Obeso JA. Dorsal subthalamotomy for Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 16: 72-8. PMID 11215596 DOI: 10.1002/1531-8257(200101)16:1<72::AID-MDS1019>3.0.CO;2-6  0.88
2000 Obeso JA, Rodriguez-Oroz MC, Rodriguez M, Macias R, Alvarez L, Guridi J, Vitek J, DeLong MR. Pathophysiologic basis of surgery for Parkinson's disease. Neurology. 55: S7-12. PMID 11188978  0.88
2000 Olanow CW, Brin MF, Obeso JA. The role of deep brain stimulation as a surgical treatment for Parkinson's disease. Neurology. 55: S60-6. PMID 11188977  0.36
2000 Rodriguez-Oroz MC, Gorospe A, Guridi J, Ramos E, Linazasoro G, Rodriguez-Palmero M, Obeso JA. Bilateral deep brain stimulation of the subthalamic nucleus in Parkinson's disease. Neurology. 55: S45-51. PMID 11188975  1
2000 Olanow CW, Obeso JA. Pulsatile stimulation of dopamine receptors and levodopa-induced motor complications in Parkinson's disease: implications for the early use of COMT inhibitors. Neurology. 55: S72-7; discussion S7. PMID 11147513  0.36
2000 Schapira AH, Obeso JA, Olanow CW. The place of COMT inhibitors in the armamentarium of drugs for the treatment of Parkinson's disease. Neurology. 55: S65-8; discussion S6. PMID 11147512  0.36
2000 Obeso JA, Rodriguez-Oroz MC, Chana P, Lera G, Rodriguez M, Olanow CW. The evolution and origin of motor complications in Parkinson's disease. Neurology. 55: S13-20; discussion S. PMID 11147505  0.36
2000 Hirsch EC, Périer C, Orieux G, François C, Féger J, Yelnik J, Vila M, Levy R, Tolosa ES, Marin C, Trinidad Herrero M, Obeso JA, Agid Y. Metabolic effects of nigrostriatal denervation in basal ganglia. Trends in Neurosciences. 23: S78-85. PMID 11052224  0.88
2000 Obeso JA, Rodríguez-Oroz MC, Rodríguez M, Lanciego JL, Artieda J, Gonzalo N, Olanow CW. Pathophysiology of the basal ganglia in Parkinson's disease. Trends in Neurosciences. 23: S8-19. PMID 11052215  1
2000 Obeso JA, Olanow CW, Nutt JG. Levodopa motor complications in Parkinson's disease. Trends in Neurosciences. 23: S2-7. PMID 11052214  0.36
2000 Guridi J, Ramos E, Linazasoro G, Obeso JA. Excitotoxic ablation. Journal of Neurosurgery. 93: 364-6. PMID 10930028  1
2000 Linazasoro G, Guridi J, Rodríguez MC, Gorospe A, Ramos E, Ruibal M, Obeso JA. [Surgery of the subthalamic nucleus in Parkinson's disease]. Revista De Neurologia. 30: 1066-72. PMID 10904955  1
2000 Krack P, Dowsey PL, Benabid AL, Acarin N, Benazzouz A, Künig G, Leenders KL, Obeso JA, Pollak P. Ineffective subthalamic nucleus stimulation in levodopa-resistant postischemic parkinsonism. Neurology. 54: 2182-4. PMID 10851392  0.88
2000 Jahanshahi M, Ardouin CM, Brown RG, Rothwell JC, Obeso J, Albanese A, Rodriguez-Oroz MC, Moro E, Benabid AL, Pollak P, Limousin-Dowsey P. The impact of deep brain stimulation on executive function in Parkinson's disease. Brain : a Journal of Neurology. 123: 1142-54. PMID 10825353  1
2000 Olanow CW, Obeso JA. Preventing levodopa-induced dyskinesias. Annals of Neurology. 47: S167-76; discussion . PMID 10762145  0.36
2000 Obeso JA, Rodriguez-Oroz MC, Rodriguez M, DeLong MR, Olanow CW. Pathophysiology of levodopa-induced dyskinesias in Parkinson's disease: problems with the current model. Annals of Neurology. 47: S22-32; discussion S. PMID 10762129  0.88
2000 Obeso JA, Linazasoro G, Guridi J, Ramos E, Rodriguez-Oroz MC. High frequency stimulation of the subthalamic nucleus and levodopa induced dyskinesias in Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 68: 122-3. PMID 10671136  1
2000 Linazasoro G, Obeso JA, Gorospe A, Rodríguez MC, Guridi J, Ramos E. Efficacy of levodopa therapy on motor function after posteroventral pallidotomy for Parkinson's disease. Neurology. 54: 535-6. PMID 10668742  1
1999 Agid Y, Ahlskog E, Albanese A, Calne D, Chase T, De Yebenes J, Factor S, Fahn S, Gershanik O, Goetz C, Koller W, Kurth M, Lang A, Lees A, Lewitt P, ... ... Obeso J, et al. Levodopa in the treatment of Parkinson's disease: a consensus meeting. Movement Disorders : Official Journal of the Movement Disorder Society. 14: 911-3. PMID 10584663 DOI: 10.1002/1531-8257(199911)14:6<911::AID-MDS1001>3.0.CO;2-H  0.88
1999 Linazasoro G, Obeso JA, Gómez JC, Martínez M, Antonini A, Leenders KL. Modification of dopamine D2 receptor activity by pergolide in Parkinson's disease: an in vivo study by PET. Clinical Neuropharmacology. 22: 277-80. PMID 10516878  0.88
1999 Guridi J, Gorospe A, Ramos E, Linazasoro G, Rodriguez MC, Obeso JA. Stereotactic targeting of the globus pallidus internus in Parkinson's disease: imaging versus electrophysiological mapping. Neurosurgery. 45: 278-87; discussion 2. PMID 10449072  1
1999 Obeso JA. [The life and work of C. David Marsden (1938-1998)]. Neurología (Barcelona, Spain). 14: 259-61. PMID 10439618  0.01
1999 Obeso JA, Linazasoro G, Gorospe A, Rodríguez MC, Guridi J, Ramos E. [Pathophysiological bases, clinical results and indications for surgical treatment in Parkinson disease]. Neurología (Barcelona, Spain). 14: 54-71. PMID 10377730  1
1999 Brown RG, Dowsey PL, Brown P, Jahanshahi M, Pollak P, Benabid AL, Rodriguez-Oroz MC, Obeso J, Rothwell JC. Impact of deep brain stimulation on upper limb akinesia in Parkinson's disease. Annals of Neurology. 45: 473-88. PMID 10211472  1
1999 Linazasoro G, Gorospe A, Rodríguez MC, Guridi J, Ramos E, Mozo A, Obeso JA. [Pallidotomy in the treatment of complicated Parkinson's disease: clinical results at two years and analysis of prognostic factors]. Neurología (Barcelona, Spain). 14: 53-61. PMID 10100420  1
1999 Limousin P, Brown RG, Jahanshahi M, Asselman P, Quinn NP, Thomas D, Obeso JA, Rothwell JC. The effects of posteroventral pallidotomy on the preparation and execution of voluntary hand and arm movements in Parkinson's disease. Brain : a Journal of Neurology. 122: 315-27. PMID 10071059  1
1998 Linazasoro G, Gorospe A, Rodríguez MC, Obeso JA. Alleviation of sulpiride induced tardive akathisia by olanzapine: case report. Neurología (Barcelona, Spain). 13: 441-2. PMID 9883021  1
1998 Rodriguez MC, Guridi OJ, Alvarez L, Mewes K, Macias R, Vitek J, DeLong MR, Obeso JA. The subthalamic nucleus and tremor in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 13: 111-8. PMID 9827606  0.88
1998 Rodriguez MC, Obeso JA, Olanow CW. Subthalamic nucleus-mediated excitotoxicity in Parkinson's disease: a target for neuroprotection. Annals of Neurology. 44: S175-88. PMID 9749591  0.36
1998 Rothwell JC, Higuchi K, Obeso JA. The offset cortical potential: an electrical correlate of movement inhibition in man. Movement Disorders : Official Journal of the Movement Disorder Society. 13: 330-5. PMID 9539349 DOI: 10.1002/mds.870130221  1
1997 Linazasoro G, Guridi J, Vela L, Gorospe A, Rodríguez MC, Aguilar M, Ramos E, Tolosa E, Obeso JA. [Stereotactic surgery in Parkinson's disease]. Neurología (Barcelona, Spain). 12: 343-53. PMID 9471164  1
1997 Marsden CD, Linazasoro G, Obeso JA. An introduction to the new surgery for Parkinson's disease. Past and present problems. Advances in Neurology. 74: 143-7. PMID 9348409  1
1997 Obeso JA, Rodriguez MC, DeLong MR. Basal ganglia pathophysiology. A critical review. Advances in Neurology. 74: 3-18. PMID 9348398  0.88
1997 Samuel M, Ceballos-Baumann AO, Turjanski N, Boecker H, Gorospe A, Linazasoro G, Holmes AP, DeLong MR, Vitek JL, Thomas DG, Quinn NP, Obeso JA, Brooks DJ. Pallidotomy in Parkinson's disease increases supplementary motor area and prefrontal activation during performance of volitional movements an H2(15)O PET study. Brain : a Journal of Neurology. 120: 1301-13. PMID 9278624 DOI: 10.1093/brain/120.8.1301  0.88
1997 Burleigh-Jacobs A, Horak FB, Nutt JG, Obeso JA. Step initiation in Parkinson's disease: influence of levodopa and external sensory triggers. Movement Disorders : Official Journal of the Movement Disorder Society. 12: 206-15. PMID 9087979 DOI: 10.1002/mds.870120211  0.88
1997 Levy R, Hazrati LN, Herrero MT, Vila M, Hassani OK, Mouroux M, Ruberg M, Asensi H, Agid Y, Féger J, Obeso JA, Parent A, Hirsch EC. Re-evaluation of the functional anatomy of the basal ganglia in normal and Parkinsonian states. Neuroscience. 76: 335-43. PMID 9015319 DOI: 10.1016/S0306-4522(96)00409-5  0.88
1996 Herrero MT, Augood SJ, Asensi H, Hirsch EC, Agid Y, Obeso JA, Emson PC. Effects of L-DOPA-therapy on dopamine D2 receptor mRNA expression in the striatum of MPTP-intoxicated parkinsonian monkeys. Brain Research. Molecular Brain Research. 42: 149-55. PMID 8915594 DOI: 10.1016/S0169-328X(96)00157-X  0.88
1996 Obeso JA, Linazasoro G, Rothwell JC, Jahanshahi M, Brown R. Assessing the effects of pallidotomy in Parkinson's disease. Lancet. 347: 1490. PMID 8676663  1
1995 Obeso JA, Artieda J, Burleigh A. Clinical aspects of negative myoclonus. Advances in Neurology. 67: 1-7. PMID 8848962  1
1995 Herrero MT, Augood SJ, Hirsch EC, Javoy-Agid F, Luquin MR, Agid Y, Obeso JA, Emson PC. Effects of L-DOPA on preproenkephalin and preprotachykinin gene expression in the MPTP-treated monkey striatum. Neuroscience. 68: 1189-98. PMID 8544992 DOI: 10.1016/0306-4522(95)00120-8  0.88
1995 Obeso JA, Guridi J, Linazasoro G, Ramos E. Hemiballism in Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 58: 645-7. PMID 7745426  1
1995 Obeso JA, Labres JL, Barajas F, Enriquez E. Supplementary motor area activation preceding externally triggered movements. Annals of Neurology. 37: 282-4. PMID 7710526 DOI: 10.1002/ana.410370223  0.88
1995 Lang AE, Benabid AL, Koller WC, Lozano AM, Obeso JA, Olanow CW, Pollak P. The core assessment program for intracerebral transplantation. Movement Disorders : Official Journal of the Movement Disorder Society. 10: 527-8. PMID 7565843 DOI: 10.1002/mds.870100426  0.36
1994 Rodríguez M, Artieda J, Zubieta JL, Obeso JA. [Olivopontocerebellar atrophy and Parkinson's disease: diagnostic problems]. Neurología (Barcelona, Spain). 9: 4-11. PMID 8161468  1
1994 Rodriguez ME, Artieda J, Zubieta JL, Obeso JA. Reflex myoclonus in olivopontocerebellar atrophy. Journal of Neurology, Neurosurgery, and Psychiatry. 57: 316-9. PMID 8158179  1
1994 Marsden CD, Obeso JA. The functions of the basal ganglia and the paradox of stereotaxic surgery in Parkinson's disease. Brain : a Journal of Neurology. 117: 877-97. PMID 7922472  1
1994 Ceballos-Baumann AO, Obeso JA, Vitek JL, Delong MR, Bakay R, Linazasoro G, Brooks DJ. Restoration of thalamocortical activity after posteroventral pallidotomy in Parkinson's disease. Lancet (London, England). 344: 814. PMID 7916090 DOI: 10.1016/S0140-6736(94)92369-8  0.88
1993 Larumbe R, Vaamonde J, Artieda J, Zubieta JL, Obeso JA. Reflex blepharospasm associated with bilateral basal ganglia lesion. Movement Disorders : Official Journal of the Movement Disorder Society. 8: 198-200. PMID 8474489 DOI: 10.1002/mds.870080215  1
1993 Bhatt MH, Obeso JA, Marsden CD. Time course of postanoxic akinetic-rigid and dystonic syndromes. Neurology. 43: 314-7. PMID 8437695  1
1993 Herrero MT, Ruberg M, Hirsch EC, Mouatt A, Tobin AJ, Agid Y, Obeso JA, Javoy-Agid F. In situ hybridization of GAD mRNA in monkey and human brain: quantification at both regional and cellular levels. Neuroscience Letters. 157: 57-61. PMID 8233032 DOI: 10.1016/0304-3940(93)90642-X  0.88
1993 Artieda J, Obeso JA. The pathophysiology and pharmacology of photic cortical reflex myoclonus. Annals of Neurology. 34: 175-84. PMID 8101703 DOI: 10.1002/ana.410340213  1
1992 Pastor MA, Jahanshahi M, Artieda J, Obeso JA. Performance of repetitive wrist movements in Parkinson's disease. Brain : a Journal of Neurology. 115: 875-91. PMID 1628206  1
1992 Thompson PD, Colebatch JG, Brown P, Rothwell JC, Day BL, Obeso JA, Marsden CD. Voluntary stimulus-sensitive jerks and jumps mimicking myoclonus or pathological startle syndromes. Movement Disorders : Official Journal of the Movement Disorder Society. 7: 257-62. PMID 1620144 DOI: 10.1002/mds.870070312  1
1992 Artieda J, Muruzabal J, Larumbe R, García de Casasola C, Obeso JA. Cortical mechanisms mediating asterixis. Movement Disorders : Official Journal of the Movement Disorder Society. 7: 209-16. PMID 1620137 DOI: 10.1002/mds.870070304  1
1992 Pastor MA, Artieda J, Jahanshahi M, Obeso JA. Time estimation and reproduction is abnormal in Parkinson's disease. Brain : a Journal of Neurology. 115: 211-25. PMID 1559155  1
1992 Artieda J, Pastor MA, Lacruz F, Obeso JA. Temporal discrimination is abnormal in Parkinson's disease. Brain : a Journal of Neurology. 115: 199-210. PMID 1559154  1
1992 Vaamonde J, Muruzabal J, Tuñón T, Perez N, Artieda J, Rodriguez M, Obeso JA. Abnormal muscle and skin mitochondria in family with myoclonus, ataxia, and deafness (May and White syndrome). Journal of Neurology, Neurosurgery, and Psychiatry. 55: 128-32. PMID 1538218  1
1992 Luquin MR, Scipioni O, Vaamonde J, Gershanik O, Obeso JA. Levodopa-induced dyskinesias in Parkinson's disease: clinical and pharmacological classification. Movement Disorders : Official Journal of the Movement Disorder Society. 7: 117-24. PMID 1350058 DOI: 10.1002/mds.870070204  0.88
1991 Artieda J, Quesada P, Obeso JA. Reciprocal inhibition between forearm muscles in spastic hemiplegia. Neurology. 41: 286-9. PMID 1992378  1
1991 Papa SM, Artieda J, Obeso JA. Cortical activity preceding self-initiated and externally triggered voluntary movement. Movement Disorders : Official Journal of the Movement Disorder Society. 6: 217-24. PMID 1922126 DOI: 10.1002/mds.870060305  0.88
1991 Obeso JA, Artieda J, Martinez-Lage JM. Dopaminergic photosensitivity. Neurology. 41: 612. PMID 1901398  1
1991 Obeso JA, Luquín MR, Artieda J, Herrero MT, Pastor MA, Guridi J. [Anatomo-functional basis for Parkinson's disease]. Archivos De Neurobiologiá. 54: 272-6. PMID 1811458  1
1991 Lacruz F, Artieda J, Pastor MA, Obeso JA. The anatomical basis of somaesthetic temporal discrimination in humans. Journal of Neurology, Neurosurgery, and Psychiatry. 54: 1077-81. PMID 1783921 DOI: 10.1136/jnnp.54.12.1077  0.88
1991 Vaamonde J, Artieda J, Obeso JA. Hereditary paroxysmal ataxia with neuromyotonia. Movement Disorders : Official Journal of the Movement Disorder Society. 6: 180-2. PMID 1647493 DOI: 10.1002/mds.870060218  1
1990 Nakashima K, Rothwell JC, Thompson PD, Day BL, Berardelli A, Agostino R, Artieda J, Papas SM, Obeso JA, Marsden CD. The blink reflex in patients with idiopathic torsion dystonia. Archives of Neurology. 47: 413-6. PMID 2322135  1
1990 Artieda J, Luquin MR, Vaamonde J, Laguna J, Obeso JA. Generalized reflex myoclonus in a patient with alcohol-sensitive spontaneous myoclonus and an abnormal gait. Movement Disorders : Official Journal of the Movement Disorder Society. 5: 85-8. PMID 2296265 DOI: 10.1002/mds.870050120  1
1990 Marsden CD, Harding AE, Obeso JA, Lu CS. Progressive myoclonic ataxia (the Ramsay Hunt syndrome). Archives of Neurology. 47: 1121-5. PMID 2121121  1
1989 Obeso JA, Grandas F, Vaamonde J, Luquin MR, Artieda J, Lera G, Rodriguez ME, Martinez-Lage JM. Motor complications associated with chronic levodopa therapy in Parkinson's disease. Neurology. 39: 11-9. PMID 2685647  1
1989 Obeso JA, Artieda J, Rothwell JC, Day B, Thompson P, Marsden CD. The treatment of severe action myoclonus. Brain : a Journal of Neurology. 112: 765-77. PMID 2499399  1
Show low-probability matches.